13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
ISSUER PROFILE · CIK 0001853921 · CUSIP 811033109

Scribe Therapeutics, Inc.SCTX

1 13D/G filings 1 distinct filers 11 insider transactions (365d)

Cross-Reference Snapshot

Activist filings
1
1 SCHEDULE 13D
Distinct filers
1
single filer
Insiders (365d)
11
11 buys · 0 sales
Latest short DTC
no FINRA match

13D/G Filings Timeline · 1 total

FiledFormFilerStakeSharesIntent
2026-07-29 SCHEDULE 13D ORBIMED ADVISORS LLC 7.20% 1,348,825 view →

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-07-28 Aghazadeh Behzad director, 10%+ Buy 7,905 $18.25 $144K
2026-07-24 Aghazadeh Behzad director, 10%+ Buy 2,333,333 $15.00 $35.00M
2026-07-24 Aghazadeh Behzad director, 10%+ Buy 50,000 $22.31 $1.12M
2026-07-23 Lucas Svetlana officer Buy 3,000 $15.00 $45K
2026-07-23 Lucas Svetlana officer Award 109,426 $15.00 $1.64M
2026-07-23 Oakes Benjamin L. director, officer Award 264,784 $15.00 $3.97M
2026-07-23 Oakes Benjamin L. director, officer Award 429,599 $15.00 $6.44M
2026-07-23 GORDON CARL L director Award 14,725 $15.00 $221K
2026-07-23 Watson James Dean director Award 14,725 $15.00 $221K
2026-03-13 Lucas Svetlana officer Award 9,547 $19.13 $183K
2026-03-13 Oakes Benjamin L. director, officer Award 12,969 $19.13 $248K

Alert me when any activist files on Scribe Therapeutics, Inc.

Free. We email you when criteria match. One-click unsubscribe in every email.

Track every activist who touches this name.

Custom alerts · full feed · daily intelligence · API. From $49/mo.

See pricing →